Enochian Biosciences Total Current Liabilities

Enochian Biosciences (ENOB) currently reports a total current liabilities of $19M as of March 2026. That compares with $29M in the prior-year period — down 33.1% year over year. Use the charts on this page to explore Enochian Biosciences's total current liabilities history and peer comparisons.

Enochian Biosciences's total current liabilities decreased from $29M to $19M — a 33.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enochian Biosciences reported $19M in total current liabilities as of March 2026. That compares with $29M in the prior-year period — down 33.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enochian Biosciences, and consider following ENOB for alerts when major investors trade the stock.

Enochian Biosciences is classified in the Healthcare sector. On total current liabilities, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENOB with unrelated industries.